Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Using Procalcitonin to Guide Antibiotic Therapy.

Rhee C.

Open Forum Infect Dis. 2016 Dec 7;4(1):ofw249. doi: 10.1093/ofid/ofw249. eCollection 2017 Winter. Review.

2.

Practice Patterns and Outcomes Associated With Procalcitonin Use in Critically Ill Patients With Sepsis.

Chu DC, Mehta AB, Walkey AJ.

Clin Infect Dis. 2017 Jun 1;64(11):1509-1515. doi: 10.1093/cid/cix179.

PMID:
28329238
3.

Determining the Clinical Utility of an Absolute Procalcitonin Value for Predicting a Positive Culture Result.

Caffarini EM, DeMott J, Patel G, Lat I.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02007-16. doi: 10.1128/AAC.02007-16. Print 2017 May.

PMID:
28193661
4.

Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples.

Garrigan C, Han J, Tolomeo P, Johnson KJ, Master SR, Lautenbach E, Nachamkin I.

Am J Transl Res. 2016 Oct 15;8(10):4362-4369. eCollection 2016.

5.

Early management of sepsis.

Vincent JL, Pereira AJ, Gleeson J, Backer D.

Clin Exp Emerg Med. 2014 Sep 30;1(1):3-7. eCollection 2014 Sep. Review.

6.

AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital.

Zhang Z, Smischney NJ, Zhang H, Van Poucke S, Tsirigotis P, Rello J, Honore PM, Sen Kuan W, Ray JJ, Zhou J, Shang Y, Yu Y, Jung C, Robba C, Taccone FS, Caironi P, Grimaldi D, Hofer S, Dimopoulos G, Leone M, Hong SB, Bahloul M, Argaud L, Kim WY, Spapen HD, Rocco JR.

J Thorac Dis. 2016 Sep;8(9):2654-2665. Review.

7.

Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit.

Lautz AJ, Dziorny AC, Denson AR, O'Connor KA, Chilutti MR, Ross RK, Gerber JS, Weiss SL.

J Pediatr. 2016 Dec;179:74-81.e2. doi: 10.1016/j.jpeds.2016.07.045. Epub 2016 Aug 29.

PMID:
27587074
8.

Emerging infection and sepsis biomarkers: will they change current therapies?

Jacobs L, Wong HR.

Expert Rev Anti Infect Ther. 2016 Oct;14(10):929-41. doi: 10.1080/14787210.2016.1222272. Epub 2016 Aug 17.

PMID:
27533847
9.

Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections.

Nobre V, Borges I; Núcleo Interdisciplinar de Investigação em Medicina Intensiva (NIIMI)..

Rev Bras Ter Intensiva. 2016 Jun;28(2):179-89. doi: 10.5935/0103-507X.20160019. Review. English, Portuguese. No abstract available.

10.

Implementation of a procalcitonin-guided algorithm for antibiotic therapy in the burn intensive care unit.

Lavrentieva A, Kontou P, Soulountsi V, Kioumis J, Chrysou O, Bitzani M.

Ann Burns Fire Disasters. 2015 Sep 30;28(3):163-70.

11.

Advances in antibiotic therapy in the critically ill.

Vincent JL, Bassetti M, François B, Karam G, Chastre J, Torres A, Roberts JA, Taccone FS, Rello J, Calandra T, De Backer D, Welte T, Antonelli M.

Crit Care. 2016 May 17;20(1):133. doi: 10.1186/s13054-016-1285-6. Review.

12.

Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK.

Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.

13.

Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, Geiss HK, Janata O, Krause R, Lemmen S, Meyer E, Mittermayer H, Porsche U, Presterl E, Reuter S, Sinha B, Strauß R, Wechsler-Fördös A, Wenisch C, Kern WV.

Infection. 2016 Jun;44(3):395-439. doi: 10.1007/s15010-016-0885-z.

14.

Antimicrobial Stewardship: The Need to Cover All Bases.

Friedman ND.

Antibiotics (Basel). 2013 Aug 27;2(3):400-18. doi: 10.3390/antibiotics2030400. Review.

15.

Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.

Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program..

Diagn Microbiol Infect Dis. 2016 May;85(1):109-15. doi: 10.1016/j.diagmicrobio.2016.01.003. Epub 2016 Jan 8.

16.

Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?

Di Pasquale M, Aliberti S, Mantero M, Bianchini S, Blasi F.

Int J Mol Sci. 2016 Feb 25;17(3):287. doi: 10.3390/ijms17030287. Review.

17.

Urosepsis--Etiology, Diagnosis, and Treatment.

Dreger NM, Degener S, Ahmad-Nejad P, Wöbker G, Roth S.

Dtsch Arztebl Int. 2015 Dec 4;112(49):837-47; quiz 848. doi: 10.3238/arztebl.2015.0837. Review.

18.

Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture Results in Patients With Suspected Bloodstream Infection: An Observational Study of 35,343 Consecutive Patients (A STROBE-Compliant Article).

Oussalah A, Ferrand J, Filhine-Tresarrieu P, Aissa N, Aimone-Gastin I, Namour F, Garcia M, Lozniewski A, Guéant JL.

Medicine (Baltimore). 2015 Nov;94(44):e1774. doi: 10.1097/MD.0000000000001774.

19.

Procalcitonin Kinetics in the First 72 Hours Predicts 30-Day Mortality in Severely Ill Septic Patients Admitted to an Intermediate Care Unit.

Pieralli F, Vannucchi V, Mancini A, Antonielli E, Luise F, Sammicheli L, Turchi V, Para O, Bacci F, Nozzoli C.

J Clin Med Res. 2015 Sep;7(9):706-13. doi: 10.14740/jocmr2251w. Epub 2015 Jul 24.

20.

Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit.

Carr JA.

J Intensive Care. 2015 Aug 4;3(1):36. doi: 10.1186/s40560-015-0100-9. eCollection 2015. Review.

Supplemental Content

Support Center